| Literature DB >> 31111052 |
Yamuna Siriwardana1, Guofa Zhou2, Bhagya Deepachandi1, Janaka Akarawita3, Chandanie Wickremarathne3, Wipula Warnasuriya4, Chandanie Udagedara5, Ranthilaka R Ranawaka6, Indira Kahawita7, Dananja Ariyawansa8, Ganga Sirimanna9, P H Chandrawansa10, Nadira D Karunaweera1.
Abstract
Sri Lanka reports a large epidemic of cutaneous leishmaniasis (CL) caused by an atypical L. donovani while regional leishmaniasis elimination drive aims at achieving its targets in 2020. Visceralization, mucotrophism, and CL associated poor treatment response were recently reported. Long-term clinico-epidemiological trends (2001-2013) in this focus were examined for the first time. Both constant and changing features were observed. Sociodemographic patient characteristics that differ significantly from those of country profile, microchanges within CL profile, spatial expansion, constant biannual seasonal variation, and nondependency of clinical profile on age or gender were evident. Classical CL remains the main clinical entity without clinical evidence for subsequent visceralization indicating presence of parasite strain variation. These observations make a scientific platform for disease control preferably timed based on seasonal variation and highlights the importance of periodic and continued surveillance of clinic-epidemiological and other characteristics.Entities:
Mesh:
Year: 2019 PMID: 31111052 PMCID: PMC6487155 DOI: 10.1155/2019/4093603
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Spatial distribution of passively detected patients with CL in Sri Lanka during the study period (2001-2013). (a) 2001-2004, (b) 2005-2007, (c) 2008-2010, and (d) 2011-2013.
Figure 2Seasonal variation of CL case presentation in the study population over the epidemic. A low transmission season was observed from March to June and a major high referral season was observed from July to November.
Summary of clinical cases reported (2001-2013).
| Parameter | Case incidence | Composition (%) | Composition from census (%) | |
|---|---|---|---|---|
| Total cases | 1,627 | |||
| Sex | Male | 1,102 | 67.7 | 49.0 |
| Female | 525 | 32.3 | 51.0 | |
| Age (years) | ≤ 20 | 379 | 23.3 | 34.1 |
| 20~40 | 759 | 46.6 | 31.2 | |
| > 40 | 489 | 30.1 | 34.7 |
Figure 3Composition of clinical cases within the study period. (a) Composition of sex, (b) composition of age groups; study period: A-2001-2004; B-2005-2007; C-2008-2010; D-2011-2013.
Figure 4Trends in the clinical profile of study population over time (2001-2013). The individual figures show the variation of (a) number of lesions, (b) size of lesions, (c) location of lesion, (d) type of lesion, (e) itchiness associated with lesions, and (f) duration of lesions.
Trends in the clinical profile over the study period.
| Clinical parameter | Total | Chi | df | P value | |
|---|---|---|---|---|---|
| No. | (%) | ||||
| Single | 846 | 86.4 | 64.9 | 3 | <0.0001 |
| Multiple | 133 | 13.6 | |||
| Total | 979 | 100.0 | |||
|
| |||||
| Exposed area | 893 | 88.7 | 1.2 | 3 | 0.74887 |
| Covered areas | 114 | 11.3 | |||
| Total | 1007 | 100.0 | |||
|
| |||||
| Less than 2cm | 672 | 65.0 | 51.4 | 3 | <0.0001 |
| larger | 362 | 35.0 | |||
| Total | 1034 | 100.0 | |||
|
| |||||
| Nonulcerative | 509 | 49.5 | 22.5 | 3 | <0.0001 |
| Ulcerative | 519 | 50.5 | |||
| Total | 1028 | 100.0 | |||
|
| |||||
| Up to 6months | 764 | 74.1 | 39.2 | 12 | <0.0001 |
| 7-12 months | 200 | 19.4 | |||
| Over 12 | 67 | 6.5 | |||
| Total | 1031 | 100.0 | |||
|
| |||||
| Lesion associated itchiness at anytime | 61 | 18.4 | 107.9 | 6 | <0.0001 |
| Never | 271 | 81.6 | |||
| Total | 332 | 100.0 | |||
∗Missing cases or variables were excluded.
Trends in mean durations of lesion according to selected clinical features.
| Feature | Group A | Group B | Group C | Group D | Total group |
|---|---|---|---|---|---|
| MLD | 7.7 (8.8) | 6.9 (5.9) | 5.2 (5.4) | 7.0 (9.8) | 6.64 (12.3) |
| MLD (SD) of single lesions | 7.5 (7.6) | 7.06 (6.1) | 5.2 (5.4) | 6.2 (6.7) | 6.4 (12.5) |
| MLD (SD) of <2cm lesions | 6.7 (8.2) | 6.9 (5.7) | 5.3 (5.8) | 6.2 (6.7) | 6.2 (6.5) |
| MLD (SD) of ulcerated lesions | 8.7 (8.9) | 7.3 (5.7) | 4.9 (5.4) | 6.2 (8.0) | 6.0 (6.1) |
∗MLD (SD): mean lesion duration in months (standard deviation).
Figure 5Trends in the sex composition in different age groups over the time. The trend remained nearly constant at different stages during the study period.
Figure 6Some common lesion stages in cutaneous leishmaniasis. (a) Popular lesion, (b) nodular lesion, (c) ulcerating nodule, and (d) ulcer.